225 Results
“When is the next NIH Advisory Committee to the Director meeting?”
Funding News Edition: June 5, 2024
Develop Tools to Tackle Antibiotic-Resistant Gram-Negative Bacteria
Funding News Edition: May 15, 2024
This opportunity will support milestone-driven projects focused on developing novel predictive models, assays, tools, or platforms aimed at gaining a better understanding of the rules and compound properties that govern the penetration and efflux of drug-like small molecules into Gram-negative bacterial pathogens.
Help End the HIV Epidemic Through Resource-Related Research Projects
Funding News Edition: May 15, 2024
NIAID will establish a Coordination, Consultation, and Data Management Center and multiple Regional Consultation Hubs to support NIH's Ending the HIV Epidemic in the U.S. Initiative research portfolio.
Develop Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus
Funding News Edition: May 15, 2024
Apply if you can further the development of new products to prevent herpes simplex virus infection and improve the diagnosis and treatment of patients living with herpes.
NIH Increases NRSA Stipend Levels, Shares Perspective
Funding News Edition: May 15, 2024
NIH announced Ruth L. Kirschstein National Research Service Award (NRSA) stipend levels for awards made on or after October 1, 2023, which saw their largest year-over-year increase since fiscal year 2017.
Learn About NIAID Career Opportunities and How to Apply
Funding News Edition: May 15, 2024
While many jobs at NIAID require expertise specific to our area of science, you'll notice that many position titles and functional roles are often similar across NIH’s many institutes and centers.
Examine Human Leukocyte Antigen, Killer-cell Immunoglobulin-like Receptor Genomics
Funding News Edition: May 15, 2024
Apply to investigate the relationship between genetic variation in human leukocyte antigen and killer-cell immunoglobulin-like receptor region genomics and immune-mediated diseases.
News Briefs and Worth Repeating
Funding News Edition: May 15, 2024
Bookmark Updated Version of NIH Grants Policy Statement; Coming Soon: Reissued Parent NOFOs for Small Business Grant Applications; Review List of NIH Legislative Mandates for Fiscal Year 2024; Grants.gov Downtime Scheduled for this Weekend
Application Viewing Window Isn’t a Due Date Loophole
Funding News Edition: May 15, 2024
If you identify a mistake or a missing form while examining your application in the viewing window, then your signing official should reject the application so that you can correct the error and submit a replacement application.
“If I receive funding as part of a multiple-PI application, do I lose my new PI status?”
Funding News Edition: May 15, 2024
“Can I attend the open portion of NIAID’s May Council meeting in person?”
Funding News Edition: May 15, 2024
RFI Seeks Input on NIAID Immunology Knowledge Management
Funding News Edition: May 15, 2024
Share feedback on existing immunology resources, future needs of the research community, and potential future directions of data and knowledge management.
NIAID Adjusts Requirements for Some Career Development, Training Awards
Funding News Edition: May 15, 2024
We announced a medley of changes for our career development and institutional training awards meant to help us better foster future investigators and maintain a balanced research training portfolio.
NIAID’s Commitment to Early-Stage Investigators in HIV Research
Funding News Edition: May 1, 2024
Senior investigators should concern themselves with the career trajectory of promising HIV researchers, and at NIAID we are exploring ways to maximize our resources to fund as many worthy candidates as possible.
News Briefs and Worth Repeating
Funding News Edition: May 1, 2024
Attend “NIH Grants Process: A Brief Walk-Through for Beginners” Event on May 15; Reminders for Small Business Concerns: TABA Supplements and Foreign Disclosures; Webinar to Discuss U54 Opportunity on Systems Modeling of Infection and Immunity
Addressing Common Misconceptions About NOSIs
Funding News Edition: May 1, 2024
NIH uses notices of special interest (NOSIs) to invite applications on high-priority and high-opportunity areas of science. NOSIs are designed to reduce administrative burden on NIH staff and grant applicants alike.
Examine Impact of Hormone Regimens on Treatment and Prevention for HIV and Co-Infections
Funding News Edition: May 1, 2024
NIAID will support studies that examine the impact of hormone therapy and antiretroviral drugs on treatment and prevention methods of HIV and other sexually transmitted infections.
Sample Grant Applications Serve as Exemplary Guides
Funding News Edition: May 1, 2024
NIAID shares sample applications to provide examples of good grantsmanship and successful approaches to presenting a Research Strategy and Specific Aims.
Explore the World of Research and Development Contract Solicitations
Funding News Edition: May 1, 2024
Contracts are government requirements for a product or service with specific goals, deliverables, and deadlines, and work done under a contract requires programmatic oversight by NIAID staff.
Join the Immunobiology of Xenotransplantation Cooperative Research Program
Funding News Edition: May 1, 2024
The Immunobiology of Xenotransplantation Cooperative Research Program supports research in preclinical nonhuman primate and human decedent models of porcine pancreatic islet, kidney, heart, lung, or liver xenotransplantation.
Request Funding to Explore Controlled Release of HIV Vaccines
Funding News Edition: May 1, 2024
Conduct product-focused research to advance controlled-release vaccine strategies shown to improve immune responses for HIV prevention, treatment, and cure, and also to develop simplified or single-shot vaccination formulations.
Propose a Multiproject Cell and Gene Therapy Research Program for HIV Cure
Funding News Edition: May 1, 2024
NIAID will support integrated multi-project research programs applying emerging and improved technologies to develop innovative gene- or cell-based HIV cure approaches. You can apply through the notice of funding opportunity (NOFO) Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01, Clinical Trial Not Allowed).We expect applicants to leverage recent insights into virus-host
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.